ESC 365 - Professor Richard Schulz

Speaker illustration

Professor Richard Schulz

Edmonton (Canada)

MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling

Date: 17 February 2020

Journal: Cardiovascular Research

Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia–reperfusion injury

Date: 20 August 2019

Journal: Cardiovascular Research

Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

Date: 4 August 2009

Journal: Cardiovascular Research

Glycogen synthase kinase-3β is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts

Date: 3 June 2009

Journal: Cardiovascular Research

Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction

Date: 1 February 2003

Journal: Cardiovascular Research

Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2

Date: 1 January 2002

Journal: Cardiovascular Research

ESC 365 is supported by

novartis

Explore sponsored resources